All Stories

  1. A guide to building the matrisome interactome: from computational predictions to experimental validation
  2. Fibronectin composition and transglutaminase 2 cross-linking cooperatively regulate ovarian cancer cell adhesion in ECM-mimetic constructs
  3. In-depth proteomic profiling of the extracellular matrix of pancreatic ductal adenocarcinomas identifies signatures correlating with lymphocyte infiltration
  4. Comparative proteomic analysis of the ECM composition of the human omentum and mesentery, the main sites of ovarian cancer metastasis
  5. MatriCom, a single-cell RNA-sequencing data mining tool to infer cell–extracellular matrix interactions
  6. Fibronectin Composition and Transglutaminase 2 Cross-linking Cooperatively Regulate Ovarian Cancer Cell Adhesion in ECM-Mimetic Constructs
  7. Time-lapse tryptic digestion: a proteomic approach to improve sequence coverage of extracellular matrix proteins
  8. The novel ECM protein SNED1 mediates cell adhesion via the RGD-binding integrins α5β1 and αvβ3
  9. MatriCom: a scRNA-Seq data mining tool to infer ECM-ECM and cell-ECM communication systems
  10. MatrixDB 2024: an increased coverage of extracellular matrix interactions, a new Network Explorer and a new web interface
  11. Proteomic insights into the extracellular matrix: a focus on proteoforms and their implications in health and disease
  12. Mechanisms of assembly and remodelling of the extracellular matrix
  13. The novel ECM protein SNED1 mediates cell adhesion via the RGD-binding integrins α5β1 and αvβ3
  14. Extracellular matrix dynamics: A key regulator of cell migration across length-scales and systems
  15. Matrisome AnalyzeR – a suite of tools to annotate and quantify ECM molecules in big datasets across organisms
  16. Desalting of Peptides to Prepare for Mass Spectrometry Analysis v2
  17. Matrisome AnalyzeR: A suite of tools to annotate and quantify ECM molecules in big datasets across organisms
  18. Ten Years of Extracellular Matrix Proteomics: Accomplishments, Challenges, and Future Perspectives
  19. Data from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  20. Data from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  21. GSEA gene sets from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  22. Ingenuity Pathway Analysis from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  23. MS data from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  24. Supplementary Figures from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  25. GSEA gene sets from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  26. Marker selection from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  27. Supplementary Tables from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  28. Ingenuity Pathway Analysis from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  29. Supplementary Figures from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  30. MS data from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  31. Supplementary Tables from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  32. Marker selection from Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  33. Compartmental Protein Extraction to Achieve Enrichment of Extracellular Matrix (ECM) Proteins v1
  34. Reduced SPAG17 Expression in Systemic Sclerosis Triggers Myofibroblast Transition and Drives Fibrosis
  35. Beyond the matrisome: New frontiers in ECM research
  36. MatrisomeDB 2.0: 2023 updates to the ECM-protein knowledge database
  37. Systematic Analysis of Actively Transcribed Core Matrisome Genes Across Tissues and Cell Phenotypes
  38. New Views of Old Proteins: Clarifying the Enigmatic Proteome
  39. Time-lapsed proteomics reveals a role for the novel protein, SNED1, in modulating ECM composition and protein folding
  40. The matrix in focus: new directions in extracellular matrix research from the 2021 ASMB hybrid meeting
  41. A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy
  42. Multi-modal Profiling of the Extracellular Matrix of Human Fallopian Tubes and Serous Tubal Intraepithelial Carcinomas
  43. Computational and experimental characterization of the novel ECM glycoprotein SNED1 and prediction of its interactome
  44. The Burden of Post-Translational Modification (PTM)—Disrupting Mutations in the Tumor Matrisome
  45. Knockout of the gene encoding the extracellular matrix protein SNED1 results in early neonatal lethality and craniofacial malformations
  46. Spatial-omics: Novel approaches to probe cell heterogeneity and extracellular matrix biology
  47. The liver matrisome – looking beyond collagens
  48. Computational and experimental characterization of the novel ECM glycoprotein SNED1 and prediction of its interactome
  49. Pan-Cancer Analysis of the Genomic Alterations and Mutations of the Matrisome
  50. Proteomic pipeline to identify age-related compositional and structural changes of the human dentin extracellular matrix
  51. Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches
  52. The Extracellular Matrix Goes -Omics: Resources and Tools
  53. The Matrisome of Model Organisms: From In-Silico Prediction to Big-Data Annotation
  54. In-silico definition of the Drosophila melanogaster matrisome
  55. MatrisomeDB: the ECM-protein knowledge database
  56. Exploring the extracellular matrix in health and disease using proteomics
  57. The in-silico characterization of the Caenorhabditis elegans matrisome and proposal of a novel collagen classification
  58. MatrixDB: integration of new data with a focus on glycosaminoglycan interactions
  59. Knockout of the gene encoding the extracellular matrix protein Sned1 results in craniofacial malformations and early neonatal lethality
  60. The cancer matrisome: From comprehensive characterization to biomarker discovery
  61. Extracellular matrix in lung development, homeostasis and disease
  62. The in-silico zebrafish matrisome: A new tool to study extracellular matrix gene and protein functions
  63. Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics
  64. Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival
  65. Proteomic characterization of human multiple myeloma bone marrow extracellular matrix
  66. Comprehensive proteomic characterization of stem cell-derived extracellular matrices
  67. Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression
  68. Lamellipodin promotes invasive 3D cancer cell migration via regulated interactions with Ena/VASP and SCAR/WAVE
  69. The extracellular matrix: Tools and insights for the “omics” era
  70. Enrichment of Extracellular Matrix Proteins from Tissues and Digestion into Peptides for Mass Spectrometry Analysis
  71. Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver
  72. Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters
  73. Towards definition of an ECM parts list: An advance on GO categories
  74. Abstract SY28-01: Multiple changes in tumor extracellular matrices
  75. Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells
  76. Ezrin regulates microvillus morphogenesis by promoting distinct activities of Eps8 proteins
  77. The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
  78. Overview of the Matrisome--An Inventory of Extracellular Matrix Constituents and Functions
  79. Emerging role for ERM proteins in cell adhesion and migration
  80. Abstract 2370: A novel Src/Ezrin pathway regulates local invasion and metastasis of breast
  81. Inhibition of endothelial cell chemotaxis toward FGF-2 by gefitinib associates with downregulation of Fes activity
  82. Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia
  83. Spatial recruitment and activation of the Fes kinase by ezrin promotes HGF-induced cell scattering